NCT00038376 2018-10-29Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesM.D. Anderson Cancer CenterPhase 2 Completed56 enrolled
NCT00098891 2013-01-24MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Completed24 enrolled